NASDAQ:BRKR - Bruker Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $30.66 -0.78 (-2.48 %) (As of 10/21/2018 04:56 AM ET)Previous Close$30.66Today's Range$30.60 - $31.645052-Week Range$28.13 - $36.53Volume382,079 shsAverage Volume687,860 shsMarket Capitalization$4.91 billionP/E Ratio25.34Dividend Yield0.51%Beta1.34 Company ProfileDiscussionAnalyst RatingsChartDividend HistoryEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology and diagnostics, chemical, food and beverage, clinical, polymer, nanotechnology, semiconductor, and industrial companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, agriculture, food and beverage safety, environmental and clinical microbiology laboratories, hospitals, and government departments and agencies; and raw material manufacturers, and other businesses involved in materials analysis. It markets its products through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts. Receive BRKR News and Ratings via Email Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Analytical instruments Sub-IndustryLife Sciences Tools & Services SectorComputer and Technology SymbolNASDAQ:BRKR CUSIP11679410 Webwww.bruker.com Phone978-663-3660 Debt Debt-to-Equity Ratio0.26 Current Ratio2.22 Quick Ratio1.27 Price-To-Earnings Trailing P/E Ratio25.34 Forward P/E Ratio22.22 P/E Growth2 Sales & Book Value Annual Sales$1.77 billion Price / Sales2.71 Cash Flow$1.6069 per share Price / Cash19.08 Book Value$4.72 per share Price / Book6.50 Profitability EPS (Most Recent Fiscal Year)$1.21 Net Income$78.60 million Net Margins4.99% Return on Equity27.03% Return on Assets10.92% Miscellaneous Employees6,200 Outstanding Shares156,320,000Market Cap$4.91 billion Bruker (NASDAQ:BRKR) Frequently Asked Questions What is Bruker's stock symbol? Bruker trades on the NASDAQ under the ticker symbol "BRKR." How often does Bruker pay dividends? What is the dividend yield for Bruker? Bruker declared a quarterly dividend on Monday, August 13th. Stockholders of record on Tuesday, September 4th will be given a dividend of $0.04 per share on Friday, September 21st. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.52%. The ex-dividend date of this dividend is Friday, August 31st. View Bruker's Dividend History. How will Bruker's stock buyback program work? Bruker announced that its Board of Directors has approved a stock repurchase plan on Sunday, June 4th 2017, which authorizes the company to buyback $225,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Stock buyback plans are usually an indication that the company's leadership believes its stock is undervalued. How were Bruker's earnings last quarter? Bruker Co. (NASDAQ:BRKR) released its quarterly earnings results on Thursday, August, 2nd. The medical research company reported $0.25 earnings per share for the quarter, meeting the consensus estimate of $0.25. The medical research company had revenue of $443.70 million for the quarter, compared to analyst estimates of $436.10 million. Bruker had a net margin of 4.99% and a return on equity of 27.03%. The company's revenue was up 6.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.23 earnings per share. View Bruker's Earnings History. When is Bruker's next earnings date? Bruker is scheduled to release their next quarterly earnings announcement on Thursday, November 1st 2018. View Earnings Estimates for Bruker. How can I listen to Bruker's earnings call? Bruker will be holding an earnings conference call on Thursday, November 1st at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8884372685. What guidance has Bruker issued on next quarter's earnings? Bruker updated its FY18 earnings guidance on Thursday, August, 2nd. The company provided earnings per share guidance of $1.34-1.38 for the period, compared to the Thomson Reuters consensus estimate of $1.38. The company issued revenue guidance of approx $1.88 billion, compared to the consensus revenue estimate of $1.88 billion. What price target have analysts set for BRKR? 9 brokerages have issued 12 month price targets for Bruker's shares. Their predictions range from $28.00 to $42.00. On average, they anticipate Bruker's share price to reach $33.8889 in the next twelve months. This suggests a possible upside of 10.5% from the stock's current price. View Analyst Price Targets for Bruker. What is the consensus analysts' recommendation for Bruker? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 2 sell ratings, 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Bruker. Who are some of Bruker's key competitors? Some companies that are related to Bruker include Waters (WAT), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Coherent (COHR), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM), Harvard Bioscience (HBIO), Eyepoint Pharmaceuticals (EYPT), HTG Molecular Diagnostics (HTGM), BioNano Genomics (BNGO), Arrayit (ARYC) and Aethlon Medical (AEMD). Who are Bruker's key executives? Bruker's management team includes the folowing people: Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 58)Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 56)Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 63)Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 60)Stacey Desrochers, Treasurer & Director of Investor Relations Who are Bruker's major shareholders? Bruker's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include MERIAN GLOBAL INVESTORS UK Ltd (0.45%), Scout Investments Inc. (0.12%), Bank of Montreal Can (0.04%), Cornerstone Wealth Management LLC (0.02%), Fox Run Management L.L.C. (0.01%) and Seven Eight Capital LP (0.01%). Company insiders that own Bruker stock include Frank H Laukien, Ingen Chris Van, Mark Munch and Richard Kniss. View Institutional Ownership Trends for Bruker. Which institutional investors are selling Bruker stock? BRKR stock was sold by a variety of institutional investors in the last quarter, including MERIAN GLOBAL INVESTORS UK Ltd, Fox Run Management L.L.C. and Strs Ohio. View Insider Buying and Selling for Bruker. Which institutional investors are buying Bruker stock? BRKR stock was acquired by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Seven Eight Capital LP, Nisa Investment Advisors LLC, First Hawaiian Bank, Scout Investments Inc., Cornerstone Wealth Management LLC and Ramsey Quantitative Systems. View Insider Buying and Selling for Bruker. How do I buy shares of Bruker? Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Bruker's stock price today? One share of BRKR stock can currently be purchased for approximately $30.66. How big of a company is Bruker? Bruker has a market capitalization of $4.91 billion and generates $1.77 billion in revenue each year. The medical research company earns $78.60 million in net income (profit) each year or $1.21 on an earnings per share basis. Bruker employs 6,200 workers across the globe. What is Bruker's official website? The official website for Bruker is http://www.bruker.com. How can I contact Bruker? Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected] MarketBeat Community Rating for Bruker (NASDAQ BRKR)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 515 (Vote Outperform)Underperform Votes: 570 (Vote Underperform)Total Votes: 1,085MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/21/2018 by MarketBeat.com StaffFeatured Article: Do stock splits help investors?